Research shows a blood test developed by MFT could benefit thousands of women eligible for preventative breast cancer drug
A hormone blood test, developed at MFT can determine the effectiveness of anastrozole, the recommended preventative treatment for post-menopausal women at high risk of developing breast cancer.
Read more